List of largest biomedical companies by revenue

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The following is a list of the top independent pharmaceutical, biotechnology and medical companies ranked by their revenue generated in (billion dollars) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue over $10 billion[edit]

Rank Chg Company 2021
USD billions 		2020
USD billions 		2019
USD billions 		2018
USD billions 		2017
USD billions 		2016
USD billions 		2015
USD billions 		2014
USD billions 		2013
USD billions 		2012
USD billions
1 Steady United States Johnson & Johnson
NYSE: JNJ 		93.78[1] 82.59[1] 82.06[2] 81.60[3] 76.50[4] 71.89[5] 70.10[6] 74.30[7] 71.31[8] 67.20[9]
2 Increase 7 United States Pfizer
NYSE: PFE 		81.29[10] 41.91[11] 41.17[11] 40.83[11] 52.54[12] 52.82[13] 48.85[14] 49.61[15] 51.58[16] 58.99[17]
3 Decrease 1 China Sinopharm
SEHK: 1099 		71.75[18] 60.18[19] 48.75[20] 43.63[21] 36.56[22] 32.36[23] 28.32[24] 23.61[25] 19.31[26]
4 Decrease 1 Switzerland Roche
SIX: ROG 		67.83[27] 62.99[27] 63.85[28] 56.86[29] 57.37[30] 50.11[31] 47.70[32] 49.86[33] 48.53[34] 47.80[35]
5 Increase 2 United States AbbVie
NYSE: ABBV 		56.20[36] 45.80[36] 33.27[37] 32.75[38] 28.22[39] 25.56[40] 22.82[41] 19.96[42] 18.79[43]
6 Decrease 2 Switzerland Novartis
NYSE: NVS 		51.63[44] 48.66[44] 47.45[45] 44.75[46] 49.11[47] 48.52[48] 49.41[49] 58.00[50] 57.36[51] 56.67[52]
7 Decrease 2 Germany Bayer
FWB: BAYN 		49.46[53] 47.40[54] 48.02[55] 45.06[56] 37.94[57] 25.27[58] 24.09[59] 25.47[60] 24.17[61] 24.30[62]
8 Increase 2 United States Merck & Co.
NYSE: MRK 		48.70[63] 41.52[63] 46.84[64] 42.30[65] 40.10[66] 39.80[67] 39.50[68] 42.24[69] 44.03[70] 47.27[71]
9 Decrease 3 United Kingdom GlaxoSmithKline
LSE: GSK 		46.91[72] 46.17[73] 43.92[74] 43.14[75] 42.05[76] 34.79[77] 29.84[78] 37.96[79] 41.61[80] 39.93[81]
10 Decrease 2 United States Bristol Myers Squibb
Nasdaq: BMY 		46.39[82] 42.52[82] 26.15[83] 22.56[84] 20.80[85] 19.43[86] 16.56[87] 15.88[88] 16.39[89] 17.62[90]
11 Steady France Sanofi
NYSE: SNY 		43.24[91] 41.27[91] 39.28[92] 39.07[93] 42.91[94] 36.57[95] 36.73[96] 43.07[97] 42.08[98] 46.41[99]
12 Steady United States Abbott Laboratories
Nasdaq: ABT 		43.08[100] 34.61[101] 31.90[102] 30.60[103] 27.39[104] 20.85[105] 20.41[106] 20.25[107] 21.85[108] 39.87[109]
13 Steady Japan Takeda Pharmaceutical
TYO: 4502 		27.76[110] 31.17[111] 19.10[112] 16.70[113] 15.96[114] 14.93 16.84 17.36 18.91
14 Steady United Kingdom/Sweden AstraZeneca
LSE: AZN 		37.42[115] 26.62[116] 24.38[117] 22.09[118] 22.47[119] 23.00[120] 24.71[121] 26.10[122] 25.71[123] 27.97[124]
15 Increase 2 United States Eli Lilly & Co
NYSE: LLY 		28.32[125] 24.54[126] 22.32[127] 21.49[128] 22.90[129] 21.22[130] 20.00[131] 19.62[132] 23.11[133] 22.60[134]
16 Steady United States Gilead Sciences
Nasdaq: GILD 		27.31[135] 24.69[135] 22.45[136] 22.13[137] 25.70[138] 30.39[138] 32.15[138] 24.47[138] 10.80[138] 9.70[138]
17 Decrease 2 United States Amgen
Nasdaq: AMGN 		25.98[139] 25.42[140] 23.40[141] 23.70[142] 22.80[143] 22.99[144] 21.66[145] 20.06[146] 18.68[147] 17.30[148]
18 Steady Germany Boehringer Ingelheim
Private 		22.40[149] 21.75[149] 21.67[150] 17.54[151] 16.41[151] 17.70[151] 18.68[151] 18.89[151]
19 Increase 1 Denmark Novo Nordisk
NYSE: NVO 		21.66[152] 19.52[152] 18.30[153] 16.99[154] 18.77[155] 16.61[156] 16.06[157] 15.83[158] 14.88[159] 13.48[160]
20 Decrease 1 Germany Merck Group
ETR: MRK 		21.40[161] 20.08[162] 18.25[163] 16.48[164] 18.70[165] 16.62[166] 14.25[167] 15.29[168] 14.73[165] 14.36[165]
21 Increase 2 Germany Siemens Healthineers
FWB: SHL 		20.61[169] 16.56[169] 16.62[170] 15.37[171] 16.56[172] 14.25[172] 14.06[172]
22 Steady United States Viatris
Nasdaq: VTRS 		17.89[173] 11.95[173]
23 Decrease 1 United States GE Healthcare
Subsidiary of General Electric 		17.73[174] 18.01[175] 19.94[176] 19.78[177] 19.02[178] 18.21[179] 17.64[180] 18.30[181] 18.20[182]
24 Increase 4 United States Regeneron Pharmaceuticals
Nasdaq: REGN 		16.07[183] 8.50[183] 7.86[184] 6.71[184] 5.87[184] 4.86[185] 4.10[186] 2.82[186] 2.10[186] 1.38[186]
25 Decrease 2 Israel Teva Pharmaceuticals
Nasdaq: TEVA 		15.88[187] 16.66[188] 16.89[189] 18.90[190] 22.40[191] 21.90[192] 20.00[193] 20.27[194] 20.31[195] 18.31[196]
26 Steady United States Baxter International
NYSE: BAX 		12.778[197] 11.63[198] 11.36[198] 11.13 [199] 10.56 [199] 10.16 [200] 9.97 [201] 10.72 [202] 14.97 [203] 14.19 [204]
27 Decrease 2 United States Biogen
Nasdaq: BIIB 		10.98[205] 13.44[205] 14.38[206] 13.45[207] 12.30[208] 11.40[209] 10.80[210] 9.70[211] 6.90[212] 5.50[213]
28 Decrease 1 Japan Astellas Pharma
TYO: 4503 		10.85[214] 11.29[214] 12.27[215] 12.07 12.63 11.48 10.49 9.25 8.92

See also[edit]

Notes[edit]

References[edit]

  1. ^ a b https://johnsonandjohnson.gcs-web.com/static-files/5db7df36-78aa-4769-84d4-a49cb3a273ba
  2. ^ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
  3. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  4. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  6. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  7. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  9. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results".
  10. ^ https://s28.q4cdn.com/781576035/files/doc_financials/2021/q4/Q4-2021-PFE-Earnings-Release.pdf[bare URL PDF]
  11. ^ a b c https://s28.q4cdn.com/781576035/files/doc_financials/2020/AR/PFE-2020-Form-10K-FINAL.pdf[bare URL PDF]
  12. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf[bare URL PDF]
  13. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf[bare URL PDF]
  14. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf[bare URL PDF]
  15. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf[bare URL PDF]
  16. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf[bare URL PDF]
  17. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf[bare URL PDF]
  18. ^ https://media-sinopharm.todayir.com/2021042308080224799730699_en.pdf[bare URL PDF]
  19. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  20. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  21. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  22. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  23. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  24. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  25. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  26. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  27. ^ a b https://www.roche.com/investors/updates/inv-update-2022-02-03.htm
  28. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
  29. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
  30. ^ "Roche reports good results in 2017". www.roche.com.
  31. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  32. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  33. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  34. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  35. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-02. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  36. ^ a b https://investors.abbvie.com/static-files/4805c635-ab17-4c3f-94dd-dc9bf18fbf8c
  37. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  38. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  39. ^ "Financial Release - AbbVie". investors.abbvie.com.
  40. ^ "Financial Release - AbbVie". investors.abbvie.com.
  41. ^ "Financial Release - AbbVie". investors.abbvie.com.
  42. ^ "Financial Release - AbbVie". investors.abbvie.com.
  43. ^ "Financial Release - AbbVie". investors.abbvie.com.
  44. ^ a b https://www.novartis.com/sites/novartis_com/files/q4-2021-media-release-en.pdf[bare URL PDF]
  45. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf[bare URL PDF]
  46. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf[bare URL PDF]
  47. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  48. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf[bare URL PDF]
  49. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf[bare URL PDF]
  50. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf[bare URL PDF]
  51. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf[bare URL PDF]
  52. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf[bare URL PDF]
  53. ^ https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf[bare URL PDF]
  54. ^ https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf[bare URL PDF]
  55. ^ "Bayer AG Annual Report 2019" (PDF). www.bayer.com.
  56. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  57. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf[bare URL PDF]
  58. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf[bare URL PDF]
  59. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf[bare URL PDF]
  60. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  61. ^ https://www.bayer.com/en/ar-2013.pdfx
  62. ^ https://www.bayer.com/en/ar-2012.pdfx
  63. ^ a b https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2021-financial-results/
  64. ^ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  65. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  66. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC.
  67. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf[bare URL PDF]
  68. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf[bare URL PDF]
  69. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf[bare URL PDF]
  70. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf[bare URL PDF]
  71. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf[bare URL PDF]
  72. ^ https://www.gsk.com/media/7383/fy-2021-us-dollar-translation.pdf[bare URL PDF]
  73. ^ https://www.gsk.com/media/6662/annual-report-2020.pdf[bare URL PDF]
  74. ^ https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf[bare URL PDF]
  75. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  76. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf[bare URL PDF]
  77. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf[bare URL PDF]
  78. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf[bare URL PDF]
  79. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf[bare URL PDF]
  80. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf[bare URL PDF]
  81. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf[bare URL PDF]
  82. ^ a b https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2021/BMY-Q42021-Earnings-Press-Release.pdf[bare URL PDF]
  83. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79[dead link]
  84. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  85. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  86. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  87. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  88. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  89. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  90. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf[bare URL PDF]
  91. ^ a b https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/common/docs/investors/2022_02_04_Sanofi_Q4_FY_2021_iPDF-v3.pdf?la=en
  92. ^ "Fourth quarter and full year 2019 results - Sanofi".
  93. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  94. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-09. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  95. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf[bare URL PDF]
  96. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf[bare URL PDF]
  97. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf[bare URL PDF]
  98. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf[bare URL PDF]
  99. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf[bare URL PDF]
  100. ^ https://abbott.mediaroom.com/2022-01-26-Abbott-Reports-Strong-Fourth-Quarter-2021-Results-Issues-2022-Forecast
  101. ^ https://www.abbottinvestor.com/static-files/52cadf21-4090-40fd-9857-fa58e1e25949
  102. ^ "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
  103. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  104. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  105. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  106. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  107. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  108. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  109. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  110. ^ https://www.takeda.com/499b8f/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q4_qfr_en.pdf[bare URL PDF]
  111. ^ "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
  112. ^ "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
  113. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  114. ^ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).{{cite web}}: CS1 maint: url-status (link)
  115. ^ https://www.astrazeneca.com/content/dam/az/PDF/2021/full-year/Full-year-2021-results-announcement.pdf[bare URL PDF]
  116. ^ https://www.astrazeneca.com/content/dam/az/PDF/2020/full-year/Full-year_2020_results_announcement.pdf[bare URL PDF]
  117. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf[bare URL PDF]
  118. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf[bare URL PDF]
  119. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf[bare URL PDF]
  120. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
  121. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  122. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  123. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  124. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  125. ^ https://investor.lilly.com/static-files/8f2fb9cc-d123-4baf-ace2-23cef51ce0f0
  126. ^ https://investor.lilly.com/static-files/c03e912c-c3fd-49b4-b383-fb0debe5b2f3
  127. ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
  128. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  129. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  130. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  131. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  132. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  133. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  134. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  135. ^ a b https://investors.gilead.com/static-files/107ab0e3-735c-4760-882f-c3647ea97ce2
  136. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  137. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  138. ^ a b c d e f "Investor Overview". Gilead Sciences.
  139. ^ https://investors.amgen.com/static-files/cc04ca13-faef-4672-a85a-3fd7c1df3c35
  140. ^ https://investors.amgen.com/static-files/c1b90d85-8945-4d11-8d1c-5ddc343fb699
  141. ^ "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
  142. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  143. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  144. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  145. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  146. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  147. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  148. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  149. ^ a b https://www.boehringer-ingelheim.com/sites/default/files/ARPC/AR_2020/Boehringer-Ingelheim_Summary_Report_2020.pdf[bare URL PDF]
  150. ^ www.boehringer-ingelheim.com https://www.boehringer-ingelheim.com/corporate-profile/our-company/financial-highlights. {{cite web}}: Missing or empty |title= (help)
  151. ^ a b c d e "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  152. ^ a b https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2022/novo-nordisk-annual-report-2021.pdf[bare URL PDF]
  153. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
  154. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
  155. ^ "News details". www.novonordisk.com.
  156. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  157. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  158. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  159. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  160. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  161. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2021-q4/en/2021-Q4-Report-EN.pdf[bare URL PDF]
  162. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q4/en/2020-Q4-Report-EN.pdf[bare URL PDF]
  163. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf[bare URL PDF]
  164. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  165. ^ a b c "404 page - EMD Group". www.emdgroup.com. Archived from the original on 2019-02-08. Retrieved 2019-02-09. {{cite web}}: Cite uses generic title (help)
  166. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-06-19. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  167. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-05-30. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  168. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  169. ^ a b https://cdn0.scrvt.com/0e46935d037de4ec3888566275864b37/df1896911b345f04/bc8ba64c5954/Siemens_Healthineers_Annual-Report_2021.pdf[bare URL PDF]
  170. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf[bare URL PDF]
  171. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf[bare URL PDF]
  172. ^ a b c https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf[bare URL PDF]
  173. ^ a b https://investor.viatris.com/news-releases/news-release-details/viatris-reports-strong-fourth-quarter-and-full-year-2021
  174. ^ https://www.ge.com/sites/default/files/ge_webcast_presentation_01252022.pdf[bare URL PDF]
  175. ^ https://www.ge.com/sites/default/files/GE_AR20_AnnualLetterToShareholders.pdf[bare URL PDF]
  176. ^ "General Electric Healthcare segment revenue 2008-2020".
  177. ^ "General Electric Healthcare segment revenue 2008-2020".
  178. ^ "General Electric Healthcare segment revenue 2008-2020".
  179. ^ "General Electric Healthcare segment revenue 2008-2020".
  180. ^ "General Electric Healthcare segment revenue 2008-2020".
  181. ^ "General Electric Healthcare segment revenue 2008-2020".
  182. ^ "General Electric Healthcare segment revenue 2008-2020".
  183. ^ a b https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2021-financial
  184. ^ a b c https://investor.regeneron.com/static-files/bc3a2029-09e7-4064-95d6-8f5a2094e161
  185. ^ https://investor.regeneron.com/static-files/04bf9c6c-c0ed-4dcb-ae8c-8c6da6c08d61
  186. ^ a b c d https://investor.regeneron.com/static-files/0f20ed34-4570-40e9-8bab-d769e8e3fcab
  187. ^ https://s24.q4cdn.com/720828402/files/doc_financials/2021/q4/Press-Release-Q4-2021.pdf[bare URL PDF]
  188. ^ https://s24.q4cdn.com/720828402/files/doc_financials/2020/q4/FY2020_10K_Feb.10.2021.pdf[bare URL PDF]
  189. ^ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  190. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf[bare URL PDF]
  191. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  192. ^ "Archived copy". Archived from the original on 2018-02-03. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  193. ^ "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  194. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  195. ^ "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  196. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  197. ^ https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2022/Baxter_Reports_Fourth-Quarter_and_Full-Year_2021_Results_Schedules.pdf[bare URL PDF]
  198. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/2020/ar/938b4abc-cc88-48af-83ef-8b67633f01af.pdf[bare URL PDF]
  199. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf[bare URL PDF]
  200. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf[bare URL PDF]
  201. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf[bare URL PDF]
  202. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf[bare URL PDF]
  203. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf[bare URL PDF]
  204. ^ https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf[bare URL PDF]
  205. ^ a b https://investors.biogen.com/static-files/e483fbec-6adb-4bfd-a2c0-e48d488a3256
  206. ^ https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1
  207. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  208. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  209. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-11-18. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  210. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  211. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2015-10-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  212. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-07-13. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  213. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2015-11-06. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  214. ^ a b https://www.astellas.com/jp/system/files/astellas_ar2021_en_20211126.pdf[bare URL PDF]
  215. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=List_of_largest_biomedical_companies_by_revenue&oldid=1076895434"